SEC Filing · 6-K
PRF Technologies Ltd.
PRFXNASDAQEQUITYCurrent
SEC Filing
Company context
We are a specialty pharmaceutical company focused on the reformulation of established therapeutics. Our proprietary extended-release drug-delivery system is designed to provide an extended period of post-surgical pain relief without the need for repeated dose administration while reducing the potential need for the use of opiates. In March 2025, we acquired the business operations related to an AI-driven solar analytics technology, DeepSolar.
Current securities
As-filed source
As filedOpen full document ↗